APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-tunneled Central Venous Catheter

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-tunneled Central Venous Catheter Market Outlook and Growth Opportunities 2026

25 December 2025199 pages

Choose your research edition.

Industry ResearchNon-tunneled Central Venous Catheter Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-tunneled Central Venous Catheter Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Non-tunneled Central Venous Catheter Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-tunneled Central Venous Catheter Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-tunneled Central Venous Catheter Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Non-tunneled Central Venous Catheter market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-tunneled Central Venous Catheter is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-tunneled Central Venous Catheter is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-tunneled Central Venous Catheter is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-tunneled Central Venous Catheter market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-tunneled Central Venous Catheter market include Teleflex, B. Braun, Edwards Lifesciences, Vygon Group, TuoRen, Smith Medical, SCW MEDICATH, Mozarc Medical (Medtronic) and Merit Medical Systems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-tunneled Central Venous Catheter market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-tunneled Central Venous Catheter and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-tunneled Central Venous Catheter sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-tunneled Central Venous Catheter market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-tunneled Central Venous Catheter Segment by Company

Teleflex

B. Braun

Edwards Lifesciences

Vygon Group

TuoRen

Smith Medical

SCW MEDICATH

Mozarc Medical (Medtronic)

Merit Medical Systems

Lepu Medical

Cook Medical

Branden Medical

Becton Dickinson (BD)

Baihe Medical

Non-tunneled Central Venous Catheter Segment by Type

Single-lumen

Triple-lumen

Double-lumen

Others

Non-tunneled Central Venous Catheter Segment by Application

Hospital

Clinic

Others

Non-tunneled Central Venous Catheter Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-tunneled Central Venous Catheter status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non-tunneled Central Venous Catheter market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-tunneled Central Venous Catheter significant trends, drivers, influence factors in global and regions.

6. To analyze Non-tunneled Central Venous Catheter competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-tunneled Central Venous Catheter market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-tunneled Central Venous Catheter and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-tunneled Central Venous Catheter.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-tunneled Central Venous Catheter market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-tunneled Central Venous Catheter industry.

Chapter 3: Detailed analysis of Non-tunneled Central Venous Catheter manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non-tunneled Central Venous Catheter in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non-tunneled Central Venous Catheter in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-tunneled Central Venous Catheter Industry Trends Table 2. Non-tunneled Central Venous Catheter Industry Drivers Table 3. Non-tunneled Central Venous Catheter Industry Opportunities and Challenges Table 4. Non-tunneled Central Venous Catheter Industry Restraints Table 5. Global Non-tunneled Central Venous Catheter Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-tunneled Central Venous Catheter Revenue Share by Company (2021-2026) Table 7. Global Non-tunneled Central Venous Catheter Sales Volume by Company (Units) & (2021-2026) Table 8. Global Non-tunneled Central Venous Catheter Sales Volume Share by Company (2021-2026) Table 9. Global Non-tunneled Central Venous Catheter Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Non-tunneled Central Venous Catheter Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non-tunneled Central Venous Catheter Key Company Manufacturing Base & Headquarters Table 12. Global Non-tunneled Central Venous Catheter Company, Product Type & Application Table 13. Global Non-tunneled Central Venous Catheter Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-tunneled Central Venous Catheter by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single-lumen Table 18. Significant Companies of Triple-lumen Table 19. Significant Companies of Double-lumen Table 20. Significant Companies of Others Table 21. Global Non-tunneled Central Venous Catheter Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 22. Global Non-tunneled Central Venous Catheter Sales Volume by Type (2021-2026) & (Units) Table 23. Global Non-tunneled Central Venous Catheter Sales Volume by Type (2027-2032) & (Units) Table 24. Global Non-tunneled Central Venous Catheter Sales Volume Share by Type (2021-2026) Table 25. Global Non-tunneled Central Venous Catheter Sales Volume Share by Type (2027-2032) Table 26. Global Non-tunneled Central Venous Catheter Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Non-tunneled Central Venous Catheter Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Non-tunneled Central Venous Catheter Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Non-tunneled Central Venous Catheter Sales Value Share by Type (2021-2026) Table 30. Global Non-tunneled Central Venous Catheter Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Others Table 34. Global Non-tunneled Central Venous Catheter Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 35. Global Non-tunneled Central Venous Catheter Sales Volume by Application (2021-2026) & (Units) Table 36. Global Non-tunneled Central Venous Catheter Sales Volume by Application (2027-2032) & (Units) Table 37. Global Non-tunneled Central Venous Catheter Sales Volume Share by Application (2021-2026) Table 38. Global Non-tunneled Central Venous Catheter Sales Volume Share by Application (2027-2032) Table 39. Global Non-tunneled Central Venous Catheter Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Non-tunneled Central Venous Catheter Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Non-tunneled Central Venous Catheter Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Non-tunneled Central Venous Catheter Sales Value Share by Application (2021-2026) Table 43. Global Non-tunneled Central Venous Catheter Sales Value Share by Application (2027-2032) Table 44. Global Non-tunneled Central Venous Catheter Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 45. Global Non-tunneled Central Venous Catheter Sales by Region (2021-2026) & (Units) Table 46. Global Non-tunneled Central Venous Catheter Sales Market Share by Region (2021-2026) Table 47. Global Non-tunneled Central Venous Catheter Sales by Region (2027-2032) & (Units) Table 48. Global Non-tunneled Central Venous Catheter Sales Market Share by Region (2027-2032) Table 49. Global Non-tunneled Central Venous Catheter Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Non-tunneled Central Venous Catheter Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Non-tunneled Central Venous Catheter Sales Value Share by Region (2021-2026) Table 52. Global Non-tunneled Central Venous Catheter Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Non-tunneled Central Venous Catheter Sales Value Share by Region (2027-2032) Table 54. Global Non-tunneled Central Venous Catheter Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Non-tunneled Central Venous Catheter Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Non-tunneled Central Venous Catheter Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 57. Global Non-tunneled Central Venous Catheter Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Non-tunneled Central Venous Catheter Sales by Country (2021-2026) & (Units) Table 59. Global Non-tunneled Central Venous Catheter Sales Market Share by Country (2021-2026) Table 60. Global Non-tunneled Central Venous Catheter Sales by Country (2027-2032) & (Units) Table 61. Global Non-tunneled Central Venous Catheter Sales Market Share by Country (2027-2032) Table 62. Global Non-tunneled Central Venous Catheter Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Non-tunneled Central Venous Catheter Sales Value Market Share by Country (2021-2026) Table 64. Global Non-tunneled Central Venous Catheter Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Non-tunneled Central Venous Catheter Sales Value Market Share by Country (2027-2032) Table 66. Teleflex Company Information Table 67. Teleflex Business Overview Table 68. Teleflex Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Teleflex Non-tunneled Central Venous Catheter Product Portfolio Table 70. Teleflex Recent Development Table 71. B. Braun Company Information Table 72. B. Braun Business Overview Table 73. B. Braun Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. B. Braun Non-tunneled Central Venous Catheter Product Portfolio Table 75. B. Braun Recent Development Table 76. Edwards Lifesciences Company Information Table 77. Edwards Lifesciences Business Overview Table 78. Edwards Lifesciences Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Edwards Lifesciences Non-tunneled Central Venous Catheter Product Portfolio Table 80. Edwards Lifesciences Recent Development Table 81. Vygon Group Company Information Table 82. Vygon Group Business Overview Table 83. Vygon Group Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Vygon Group Non-tunneled Central Venous Catheter Product Portfolio Table 85. Vygon Group Recent Development Table 86. TuoRen Company Information Table 87. TuoRen Business Overview Table 88. TuoRen Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. TuoRen Non-tunneled Central Venous Catheter Product Portfolio Table 90. TuoRen Recent Development Table 91. Smith Medical Company Information Table 92. Smith Medical Business Overview Table 93. Smith Medical Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Smith Medical Non-tunneled Central Venous Catheter Product Portfolio Table 95. Smith Medical Recent Development Table 96. SCW MEDICATH Company Information Table 97. SCW MEDICATH Business Overview Table 98. SCW MEDICATH Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. SCW MEDICATH Non-tunneled Central Venous Catheter Product Portfolio Table 100. SCW MEDICATH Recent Development Table 101. Mozarc Medical (Medtronic) Company Information Table 102. Mozarc Medical (Medtronic) Business Overview Table 103. Mozarc Medical (Medtronic) Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Mozarc Medical (Medtronic) Non-tunneled Central Venous Catheter Product Portfolio Table 105. Mozarc Medical (Medtronic) Recent Development Table 106. Merit Medical Systems Company Information Table 107. Merit Medical Systems Business Overview Table 108. Merit Medical Systems Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Merit Medical Systems Non-tunneled Central Venous Catheter Product Portfolio Table 110. Merit Medical Systems Recent Development Table 111. Lepu Medical Company Information Table 112. Lepu Medical Business Overview Table 113. Lepu Medical Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Lepu Medical Non-tunneled Central Venous Catheter Product Portfolio Table 115. Lepu Medical Recent Development Table 116. Cook Medical Company Information Table 117. Cook Medical Business Overview Table 118. Cook Medical Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Cook Medical Non-tunneled Central Venous Catheter Product Portfolio Table 120. Cook Medical Recent Development Table 121. Branden Medical Company Information Table 122. Branden Medical Business Overview Table 123. Branden Medical Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Branden Medical Non-tunneled Central Venous Catheter Product Portfolio Table 125. Branden Medical Recent Development Table 126. Becton Dickinson (BD) Company Information Table 127. Becton Dickinson (BD) Business Overview Table 128. Becton Dickinson (BD) Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Becton Dickinson (BD) Non-tunneled Central Venous Catheter Product Portfolio Table 130. Becton Dickinson (BD) Recent Development Table 131. Baihe Medical Company Information Table 132. Baihe Medical Business Overview Table 133. Baihe Medical Non-tunneled Central Venous Catheter Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Baihe Medical Non-tunneled Central Venous Catheter Product Portfolio Table 135. Baihe Medical Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Non-tunneled Central Venous Catheter Distributors List Table 139. Non-tunneled Central Venous Catheter Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Non-tunneled Central Venous Catheter Product Image Figure 2. Global Non-tunneled Central Venous Catheter Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-tunneled Central Venous Catheter Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non-tunneled Central Venous Catheter Sales (2021-2032) & (Units) Figure 5. Global Non-tunneled Central Venous Catheter Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Non-tunneled Central Venous Catheter Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single-lumen Image Figure 10. Triple-lumen Image Figure 11. Double-lumen Image Figure 12. Others Image Figure 13. Global Non-tunneled Central Venous Catheter Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Non-tunneled Central Venous Catheter Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Non-tunneled Central Venous Catheter Sales Volume Share by Type (2021-2032) Figure 16. Global Non-tunneled Central Venous Catheter Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Non-tunneled Central Venous Catheter Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Non-tunneled Central Venous Catheter Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Non-tunneled Central Venous Catheter Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Non-tunneled Central Venous Catheter Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Non-tunneled Central Venous Catheter Sales Volume Share by Application (2021-2032) Figure 25. Global Non-tunneled Central Venous Catheter Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Non-tunneled Central Venous Catheter Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Non-tunneled Central Venous Catheter Sales Value Share by Application (2021-2032) Figure 28. Global Non-tunneled Central Venous Catheter Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 29. Global Non-tunneled Central Venous Catheter Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Non-tunneled Central Venous Catheter Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Non-tunneled Central Venous Catheter Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Non-tunneled Central Venous Catheter Sales Value (2021-2032) & (US$ Million) Figure 33. North America Non-tunneled Central Venous Catheter Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Non-tunneled Central Venous Catheter Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Non-tunneled Central Venous Catheter Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Non-tunneled Central Venous Catheter Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Non-tunneled Central Venous Catheter Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Non-tunneled Central Venous Catheter Sales Value (2021-2032) & (US$ Million) Figure 39. South America Non-tunneled Central Venous Catheter Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Non-tunneled Central Venous Catheter Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Non-tunneled Central Venous Catheter Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Non-tunneled Central Venous Catheter Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Non-tunneled Central Venous Catheter Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Single-lumen
  • Triple-lumen
  • Double-lumen
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teleflex
  • B. Braun
  • Edwards Lifesciences
  • Vygon Group
  • TuoRen
  • Smith Medical
  • SCW MEDICATH
  • Mozarc Medical (Medtronic)
  • Merit Medical Systems
  • Lepu Medical
  • Cook Medical
  • Branden Medical
  • Becton Dickinson (BD)
  • Baihe Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-tunneled Central Venous Catheter Sales Value (2021-2032)
  4. 1.2.2 Global Non-tunneled Central Venous Catheter Sales Volume (2021-2032)
  5. 1.2.3 Global Non-tunneled Central Venous Catheter Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non-tunneled Central Venous Catheter Market Dynamics
  1. 2.1 Non-tunneled Central Venous Catheter Industry Trends
  2. 2.2 Non-tunneled Central Venous Catheter Industry Drivers
  3. 2.3 Non-tunneled Central Venous Catheter Industry Opportunities and Challenges
  4. 2.4 Non-tunneled Central Venous Catheter Industry Restraints
3 Non-tunneled Central Venous Catheter Market by Company
  1. 3.1 Global Non-tunneled Central Venous Catheter Company Revenue Ranking in 2025
  2. 3.2 Global Non-tunneled Central Venous Catheter Revenue by Company (2021-2026)
  3. 3.3 Global Non-tunneled Central Venous Catheter Sales Volume by Company (2021-2026)
  4. 3.4 Global Non-tunneled Central Venous Catheter Average Price by Company (2021-2026)
  5. 3.5 Global Non-tunneled Central Venous Catheter Company Ranking (2024-2026)
  6. 3.6 Global Non-tunneled Central Venous Catheter Company Manufacturing Base and Headquarters
  7. 3.7 Global Non-tunneled Central Venous Catheter Company Product Type and Application
  8. 3.8 Global Non-tunneled Central Venous Catheter Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non-tunneled Central Venous Catheter Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non-tunneled Central Venous Catheter Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non-tunneled Central Venous Catheter Market by Type
  1. 4.1 Non-tunneled Central Venous Catheter Type Introduction
  2. 4.1.1 Single-lumen
  3. 4.1.2 Triple-lumen
  4. 4.1.3 Double-lumen
  5. 4.1.4 Others
  6. 4.2 Global Non-tunneled Central Venous Catheter Sales Volume by Type
  7. 4.2.1 Global Non-tunneled Central Venous Catheter Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Non-tunneled Central Venous Catheter Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Non-tunneled Central Venous Catheter Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Non-tunneled Central Venous Catheter Sales Value by Type
  11. 4.3.1 Global Non-tunneled Central Venous Catheter Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Non-tunneled Central Venous Catheter Sales Value by Type (2021-2032)
  13. 4.3.3 Global Non-tunneled Central Venous Catheter Sales Value Share by Type (2021-2032)
5 Non-tunneled Central Venous Catheter Market by Application
  1. 5.1 Non-tunneled Central Venous Catheter Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Non-tunneled Central Venous Catheter Sales Volume by Application
  6. 5.2.1 Global Non-tunneled Central Venous Catheter Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-tunneled Central Venous Catheter Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Non-tunneled Central Venous Catheter Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Non-tunneled Central Venous Catheter Sales Value by Application
  10. 5.3.1 Global Non-tunneled Central Venous Catheter Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Non-tunneled Central Venous Catheter Sales Value by Application (2021-2032)
  12. 5.3.3 Global Non-tunneled Central Venous Catheter Sales Value Share by Application (2021-2032)
6 Non-tunneled Central Venous Catheter Regional Sales and Value Analysis
  1. 6.1 Global Non-tunneled Central Venous Catheter Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-tunneled Central Venous Catheter Sales by Region (2021-2032)
  3. 6.2.1 Global Non-tunneled Central Venous Catheter Sales by Region: 2021-2026
  4. 6.2.2 Global Non-tunneled Central Venous Catheter Sales by Region (2027-2032)
  5. 6.3 Global Non-tunneled Central Venous Catheter Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non-tunneled Central Venous Catheter Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non-tunneled Central Venous Catheter Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non-tunneled Central Venous Catheter Sales Value by Region (2027-2032)
  9. 6.5 Global Non-tunneled Central Venous Catheter Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non-tunneled Central Venous Catheter Sales Value (2021-2032)
  12. 6.6.2 North America Non-tunneled Central Venous Catheter Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non-tunneled Central Venous Catheter Sales Value (2021-2032)
  15. 6.7.2 Europe Non-tunneled Central Venous Catheter Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non-tunneled Central Venous Catheter Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non-tunneled Central Venous Catheter Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non-tunneled Central Venous Catheter Sales Value (2021-2032)
  21. 6.9.2 South America Non-tunneled Central Venous Catheter Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non-tunneled Central Venous Catheter Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non-tunneled Central Venous Catheter Sales Value Share by Country, 2025 VS 2032
7 Non-tunneled Central Venous Catheter Country-level Sales and Value Analysis
  1. 7.1 Global Non-tunneled Central Venous Catheter Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-tunneled Central Venous Catheter Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non-tunneled Central Venous Catheter Sales by Country (2021-2032)
  4. 7.3.1 Global Non-tunneled Central Venous Catheter Sales by Country (2021-2026)
  5. 7.3.2 Global Non-tunneled Central Venous Catheter Sales by Country (2027-2032)
  6. 7.4 Global Non-tunneled Central Venous Catheter Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non-tunneled Central Venous Catheter Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non-tunneled Central Venous Catheter Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non-tunneled Central Venous Catheter Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non-tunneled Central Venous Catheter Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non-tunneled Central Venous Catheter Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teleflex
  2. 8.1.1 Teleflex Company Information
  3. 8.1.2 Teleflex Business Overview
  4. 8.1.3 Teleflex Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teleflex Non-tunneled Central Venous Catheter Product Portfolio
  6. 8.1.5 Teleflex Recent Developments
  7. 8.2 B. Braun
  8. 8.2.1 B. Braun Company Information
  9. 8.2.2 B. Braun Business Overview
  10. 8.2.3 B. Braun Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 B. Braun Non-tunneled Central Venous Catheter Product Portfolio
  12. 8.2.5 B. Braun Recent Developments
  13. 8.3 Edwards Lifesciences
  14. 8.3.1 Edwards Lifesciences Company Information
  15. 8.3.2 Edwards Lifesciences Business Overview
  16. 8.3.3 Edwards Lifesciences Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Edwards Lifesciences Non-tunneled Central Venous Catheter Product Portfolio
  18. 8.3.5 Edwards Lifesciences Recent Developments
  19. 8.4 Vygon Group
  20. 8.4.1 Vygon Group Company Information
  21. 8.4.2 Vygon Group Business Overview
  22. 8.4.3 Vygon Group Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Vygon Group Non-tunneled Central Venous Catheter Product Portfolio
  24. 8.4.5 Vygon Group Recent Developments
  25. 8.5 TuoRen
  26. 8.5.1 TuoRen Company Information
  27. 8.5.2 TuoRen Business Overview
  28. 8.5.3 TuoRen Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 TuoRen Non-tunneled Central Venous Catheter Product Portfolio
  30. 8.5.5 TuoRen Recent Developments
  31. 8.6 Smith Medical
  32. 8.6.1 Smith Medical Company Information
  33. 8.6.2 Smith Medical Business Overview
  34. 8.6.3 Smith Medical Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Smith Medical Non-tunneled Central Venous Catheter Product Portfolio
  36. 8.6.5 Smith Medical Recent Developments
  37. 8.7 SCW MEDICATH
  38. 8.7.1 SCW MEDICATH Company Information
  39. 8.7.2 SCW MEDICATH Business Overview
  40. 8.7.3 SCW MEDICATH Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 SCW MEDICATH Non-tunneled Central Venous Catheter Product Portfolio
  42. 8.7.5 SCW MEDICATH Recent Developments
  43. 8.8 Mozarc Medical (Medtronic)
  44. 8.8.1 Mozarc Medical (Medtronic) Company Information
  45. 8.8.2 Mozarc Medical (Medtronic) Business Overview
  46. 8.8.3 Mozarc Medical (Medtronic) Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Mozarc Medical (Medtronic) Non-tunneled Central Venous Catheter Product Portfolio
  48. 8.8.5 Mozarc Medical (Medtronic) Recent Developments
  49. 8.9 Merit Medical Systems
  50. 8.9.1 Merit Medical Systems Company Information
  51. 8.9.2 Merit Medical Systems Business Overview
  52. 8.9.3 Merit Medical Systems Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merit Medical Systems Non-tunneled Central Venous Catheter Product Portfolio
  54. 8.9.5 Merit Medical Systems Recent Developments
  55. 8.10 Lepu Medical
  56. 8.10.1 Lepu Medical Company Information
  57. 8.10.2 Lepu Medical Business Overview
  58. 8.10.3 Lepu Medical Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Lepu Medical Non-tunneled Central Venous Catheter Product Portfolio
  60. 8.10.5 Lepu Medical Recent Developments
  61. 8.11 Cook Medical
  62. 8.11.1 Cook Medical Company Information
  63. 8.11.2 Cook Medical Business Overview
  64. 8.11.3 Cook Medical Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Cook Medical Non-tunneled Central Venous Catheter Product Portfolio
  66. 8.11.5 Cook Medical Recent Developments
  67. 8.12 Branden Medical
  68. 8.12.1 Branden Medical Company Information
  69. 8.12.2 Branden Medical Business Overview
  70. 8.12.3 Branden Medical Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Branden Medical Non-tunneled Central Venous Catheter Product Portfolio
  72. 8.12.5 Branden Medical Recent Developments
  73. 8.13 Becton Dickinson (BD)
  74. 8.13.1 Becton Dickinson (BD) Company Information
  75. 8.13.2 Becton Dickinson (BD) Business Overview
  76. 8.13.3 Becton Dickinson (BD) Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Becton Dickinson (BD) Non-tunneled Central Venous Catheter Product Portfolio
  78. 8.13.5 Becton Dickinson (BD) Recent Developments
  79. 8.14 Baihe Medical
  80. 8.14.1 Baihe Medical Company Information
  81. 8.14.2 Baihe Medical Business Overview
  82. 8.14.3 Baihe Medical Non-tunneled Central Venous Catheter Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Baihe Medical Non-tunneled Central Venous Catheter Product Portfolio
  84. 8.14.5 Baihe Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-tunneled Central Venous Catheter Value Chain Analysis
  2. 9.1.1 Non-tunneled Central Venous Catheter Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-tunneled Central Venous Catheter Sales Mode & Process
  6. 9.2 Non-tunneled Central Venous Catheter Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-tunneled Central Venous Catheter Distributors
  9. 9.2.3 Non-tunneled Central Venous Catheter Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst